AU3139693A - Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 - Google Patents
Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4Info
- Publication number
- AU3139693A AU3139693A AU31396/93A AU3139693A AU3139693A AU 3139693 A AU3139693 A AU 3139693A AU 31396/93 A AU31396/93 A AU 31396/93A AU 3139693 A AU3139693 A AU 3139693A AU 3139693 A AU3139693 A AU 3139693A
- Authority
- AU
- Australia
- Prior art keywords
- antagonists
- receptor
- region
- cytoplasmic domain
- human interleukin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80362191A | 1991-11-27 | 1991-11-27 | |
US803621 | 1997-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3139693A true AU3139693A (en) | 1993-06-28 |
Family
ID=25187026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31396/93A Abandoned AU3139693A (en) | 1991-11-27 | 1992-11-24 | Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0615546A1 (fr) |
JP (1) | JPH07505047A (fr) |
AU (1) | AU3139693A (fr) |
CA (1) | CA2124338A1 (fr) |
WO (1) | WO1993011234A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005183A1 (fr) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Recepteurs d'interleukine-4 |
AU3830895A (en) * | 1994-10-07 | 1996-05-02 | Amgen Boulder Inc. | Dimeric il-4 inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005183A1 (fr) * | 1988-10-31 | 1990-05-17 | Immunex Corporation | Recepteurs d'interleukine-4 |
JPH04504061A (ja) * | 1989-09-07 | 1992-07-23 | シェリング・コーポレーション | インターロイキン―4レセプター |
-
1992
- 1992-11-24 JP JP5510142A patent/JPH07505047A/ja active Pending
- 1992-11-24 EP EP92925279A patent/EP0615546A1/fr not_active Withdrawn
- 1992-11-24 CA CA002124338A patent/CA2124338A1/fr not_active Abandoned
- 1992-11-24 WO PCT/US1992/009897 patent/WO1993011234A1/fr not_active Application Discontinuation
- 1992-11-24 AU AU31396/93A patent/AU3139693A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2124338A1 (fr) | 1993-06-10 |
WO1993011234A1 (fr) | 1993-06-10 |
EP0615546A1 (fr) | 1994-09-21 |
JPH07505047A (ja) | 1995-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5194496A (en) | 5-HT4 receptor antagonists | |
AU2363492A (en) | 5-ht4 receptor antagonists | |
AU5873594A (en) | Endothelin receptor antagonists | |
AU4396193A (en) | 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists | |
AU8374491A (en) | Angiotensin II receptor antagonists | |
AU4679793A (en) | Endothelin receptor antagonists | |
AU2143295A (en) | Neurokinin receptor antagonists | |
AU5374294A (en) | 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists | |
AU2697897A (en) | Indole derivatives useful as endothelin receptor antagonists | |
AU4718093A (en) | Substituted amines as tachykinin receptor antagonists | |
AU3642795A (en) | Endothelin receptor antagonists for the treatment of emesis | |
AU4803996A (en) | Endothelin receptor antagonists | |
AU1354597A (en) | 2-substituted piperidine analogs and their use as subtype-selective nmda receptor antagonists | |
AU3276293A (en) | Angiotensin II receptor antagonists | |
AU7694496A (en) | Endothelin receptor antagonists | |
HU9600256D0 (en) | Substituted diphenyl-sulfonamides, antagonists of endothelin | |
AU4261293A (en) | 1-piperazineacetic derivatives as fibrinogen receptor antagonists | |
AU1784992A (en) | Subunit of the human interleukin-3 receptor | |
AU5506896A (en) | Human p2x4 receptor splice-variants | |
AU1298392A (en) | Stimulating factor of the neu receptor | |
AU3745795A (en) | Use of CCK-B receptor antagonists for the treatment of sleepdisorders | |
AU5455194A (en) | Substituted phthalazinones as nerotensin antagonists | |
AU2759892A (en) | N-aryl-n1-azabicyclo-ureas as 5-ht3 antagonists | |
AU647560B2 (en) | Human interleukin-5 receptor | |
AU6646396A (en) | Endothelin receptor antagonists |